Human Lung Organoids-A Novel Experimental and Precision Medicine Approach
- PMID: 37626876
- PMCID: PMC10453737
- DOI: 10.3390/cells12162067
Human Lung Organoids-A Novel Experimental and Precision Medicine Approach
Abstract
The global burden of respiratory diseases is very high and still on the rise, prompting the need for accurate models for basic and translational research. Several model systems are currently available ranging from simple airway cell cultures to complex tissue-engineered lungs. In recent years, human lung organoids have been established as highly transferrable three-dimensional in vitro model systems for lung research. For acute infectious and chronic inflammatory diseases as well as lung cancer, human lung organoids have opened possibilities for precise in vitro research and a deeper understanding of mechanisms underlying lung injury and regeneration. Human lung organoids from induced pluripotent stem cells or from adult stem cells of patients' samples introduce tools for understanding developmental processes and personalized medicine approaches. When further state-of-the-art technologies and protocols come into use, the full potential of human lung organoids can be harnessed. High-throughput assays in drug development, gene therapy, and organoid transplantation are current applications of organoids in translational research. In this review, we emphasize novel approaches in translational and personalized medicine in lung research focusing on the use of human lung organoids.
Keywords: airways; disease models; lung epithelium; organoids; personalized medicine; translational research.
Conflict of interest statement
The authors have no conflict of interest. M.W. and D.P.P. are employees of CSL Behring Innovation GmbH, Marburg, Germany and Bioscientia MVZ Labor Mittelhessen GmbH, Giessen, Germany, respectively, which was not related and has not in any way affected or influenced the content this work.
Figures




Similar articles
-
Stem Cells and Organoid Technology in Precision Medicine in Inflammation: Are We There Yet?Front Immunol. 2020 Dec 21;11:573562. doi: 10.3389/fimmu.2020.573562. eCollection 2020. Front Immunol. 2020. PMID: 33408713 Free PMC article. Review.
-
The potential of organoids in urological cancer research.Nat Rev Urol. 2017 Jul;14(7):401-414. doi: 10.1038/nrurol.2017.65. Epub 2017 May 23. Nat Rev Urol. 2017. PMID: 28534535 Free PMC article. Review.
-
Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.Wiley Interdiscip Rev Dev Biol. 2021 Nov;10(6):e399. doi: 10.1002/wdev.399. Epub 2020 Nov 3. Wiley Interdiscip Rev Dev Biol. 2021. PMID: 33145915 Review.
-
Progress and perspective of organoid technology in cancer-related translational medicine.Biomed Pharmacother. 2022 May;149:112869. doi: 10.1016/j.biopha.2022.112869. Epub 2022 Mar 28. Biomed Pharmacother. 2022. PMID: 35358798 Review.
-
Genome engineering of stem cell organoids for disease modeling.Protein Cell. 2017 May;8(5):315-327. doi: 10.1007/s13238-016-0368-0. Epub 2017 Jan 19. Protein Cell. 2017. PMID: 28102490 Free PMC article. Review.
Cited by
-
Antibacterial activity of the novel peptide Pac-525 with the RGD motif against intracellular Escherichia coli.Sci Rep. 2025 Jun 6;15(1):19995. doi: 10.1038/s41598-025-04901-9. Sci Rep. 2025. PMID: 40481070 Free PMC article.
-
Lung organoids in COPD: recent advances and future prospects.Respir Res. 2025 Feb 28;26(1):76. doi: 10.1186/s12931-025-03138-4. Respir Res. 2025. PMID: 40022099 Free PMC article. Review.
-
Differences in the Inflammatory Response and Corticoid Responsiveness of Human Lung Macrophages and Parenchymal Explants Exposed to Cigarette Smoke Extracts.Basic Clin Pharmacol Toxicol. 2025 Jun;136(6):e70046. doi: 10.1111/bcpt.70046. Basic Clin Pharmacol Toxicol. 2025. PMID: 40344364 Free PMC article.
-
Airway Organoid Models as Pivotal Tools for Unraveling Molecular Mechanisms and Therapeutic Targets in Respiratory Diseases: A Literature Review.Ther Clin Risk Manag. 2025 Jun 24;21:975-986. doi: 10.2147/TCRM.S526727. eCollection 2025. Ther Clin Risk Manag. 2025. PMID: 40584024 Free PMC article. Review.
-
Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine.MedComm (2020). 2024 Sep 21;5(10):e735. doi: 10.1002/mco2.735. eCollection 2024 Oct. MedComm (2020). 2024. PMID: 39309690 Free PMC article. Review.
References
-
- WHO Estimated Age-Standardized Mortality Rates (World) in 2020, World, Both Sexes, All Ages (excl. NMSC) [(accessed on 28 July 2023)]. Available online: https://gco.iarc.fr/today/online-analysis-multi-bars.
-
- Foreman K.J., Marquez N., Dolgert A., Fukutaki K., Fullman N., McGaughey M., Pletcher M.A., Smith A.E., Tang K., Yuan C.-W., et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052–2090. doi: 10.1016/S0140-6736(18)31694-5. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical